{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:51:31Z","timestamp":1761061891081},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,6]]},"DOI":"10.7759\/cureus.46595","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T16:59:12Z","timestamp":1696611552000},"source":"Crossref","is-referenced-by-count":4,"title":["Myopathic Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Rare Cause of Acute Kidney Injury and Cardiomyopathy"],"prefix":"10.7759","author":[{"given":"Efrain","family":"Castillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Schoenmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-6887-1","article-title":"Expanding mutation spectrum in CPT II gene: identification of four novel mutations","volume":"260","author":"Joshi PR","year":"2013","unstructured":"Joshi PR, Young P, Deschauer M, Zierz S. Expanding mutation spectrum in CPT II gene: identification of four novel mutations. J Neurol. 2013, 260:1412-4. 10.1007\/s00415-013-6887-1","journal-title":"J Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.1.37","article-title":"Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects","volume":"62","author":"Deschauer M","year":"2005","unstructured":"Deschauer M, Wieser T, Zierz S. Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects. Arch Neurol. 2005, 62:37-41. 10.1001\/archneur.62.1.37","journal-title":"Arch Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/01.lab.0000098428.51765.83","article-title":"Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review","volume":"83","author":"Sigauke E","year":"2003","unstructured":"Sigauke E, Rakheja D, Kitson K, Bennett MJ. Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review. Lab Invest. 2003, 83:1543-54. 10.1097\/01.lab.0000098428.51765.83","journal-title":"Lab Invest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.228692","article-title":"Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex","volume":"286","author":"Lee K","year":"2011","unstructured":"Lee K, Kerner J, Hoppel CL. Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex. J Biol Chem. 2011, 286:25655-62. 10.1074\/jbc.M111.228692","journal-title":"J Biol Chem"},{"key":"ref5","article-title":"Mitochondrial fatty acid oxidation disorders","author":"Roe C","year":"2001","unstructured":"Roe C, Ding J. Mitochondrial fatty acid oxidation disorders. The metabolic and molecular bases of inherited disease. Scriver CR, Beaudet AL, Valle D (ed): McGraw Hill, New York, NY; 2001. 8:2297-326."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18010082","article-title":"Muscle carnitine palmitoyltransferase II deficiency: a review of enzymatic controversy and clinical features","volume":"18","author":"Lehmann D","year":"2017","unstructured":"Lehmann D, Motlagh L, Robaa D, Zierz S. Muscle carnitine palmitoyltransferase II deficiency: a review of enzymatic controversy and clinical features. Int J Mol Sci. 2017, 18:82. 10.3390\/ijms18010082","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19102950","article-title":"Acute respiratory infection unveiling CPT II deficiency","volume":"19","author":"Blah N","year":"2018","unstructured":"Blah N, Sudri\u00e9-Arnaud B, Torre S, Marret S, Bekri S, Tebani A. Acute respiratory infection unveiling CPT II deficiency. Int J Mol Sci. 2018, 19:2950. 10.3390\/ijms19102950","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25081784","article-title":"Muscle carnitine palmitoyltransferase II (CPT II) deficiency: a conceptual approach","volume":"25","author":"Joshi PR","year":"2020","unstructured":"Joshi PR, Zierz S. Muscle carnitine palmitoyltransferase II (CPT II) deficiency: a conceptual approach. Molecules. 2020, 25:1784. 10.3390\/molecules25081784","journal-title":"Molecules"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26043","article-title":"A case of carnitine palmitoyltransferase II deficiency in Bahrain with a novel mutation","volume":"14","author":"Alsahlawi Z","year":"2022","unstructured":"Alsahlawi Z, Fadhul Z, Mahmood A, Mohamed A, Khalil M, Aljishi E. A case of carnitine palmitoyltransferase II deficiency in Bahrain with a novel mutation. Cureus. 2022, 14:e26043. 10.7759\/cureus.26043","journal-title":"Cureus"},{"key":"ref10","article-title":"","author":"Wieser T","year":"2004","unstructured":"Wieser T. Carnitine palmitoyltransferase II deficiency. Adam MP, Mirzaa GM, Pagon RA, et al. (ed): GeneReviews, Seattle, WA; 2004. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1253\/."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2018.11.023","article-title":"Phenotype of carnitine palmitoyltransferase II (CPT II) deficiency: a questionnaire-based survey","volume":"59","author":"Joshi PR","year":"2019","unstructured":"Joshi PR, Deschauer M, Zierz S. Phenotype of carnitine palmitoyltransferase II (CPT II) deficiency: a questionnaire-based survey. J Clin Neurosci. 2019, 59:32-6. 10.1016\/j.jocn.2018.11.023","journal-title":"J Clin Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijns7030055","article-title":"Detection of early onset carnitine palmitoyltransferase II deficiency by newborn screening: should CPT II deficiency be a primary disease target?","volume":"7","author":"Mador-House R","year":"2021","unstructured":"Mador-House R, Liu Z, Dyack S. Detection of early onset carnitine palmitoyltransferase II deficiency by newborn screening: should CPT II deficiency be a primary disease target?. Int J Neonatal Screen. 2021, 7:55. 10.3390\/ijns7030055","journal-title":"Int J Neonatal Screen"},{"key":"ref13","article-title":"A case report of carnitine palmitoyltransferase deficiency type II","volume":"77","author":"Singh R","year":"2022","unstructured":"Singh R, Rabi Atul Adawiyah M. A case report of carnitine palmitoyltransferase deficiency type II. Med J Malaysia. 2022, 77:98-100.","journal-title":"Med J Malaysia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-023-00804-8","article-title":"Adult-onset carnitine palmitoyl transferase II (CPT II) deficiency presenting with rhabdomyolysis and acute kidney injury","author":"Akar HT","year":"2023","unstructured":"Akar HT, Y\u0131ld\u0131z Y, Mutluay R, Tekin E, Tokatl\u0131 A. Adult-onset carnitine palmitoyl transferase II (CPT II) deficiency presenting with rhabdomyolysis and acute kidney injury. CEN Case Rep. 2023, 10.1007\/s13730-023-00804-8","journal-title":"CEN Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2013.04.008","article-title":"Differences between acylcarnitine profiles in plasma and bloodspots","volume":"110","author":"de Sain-van der Velden MG","year":"2013","unstructured":"de Sain-van der Velden MG, Diekman EF, Jans JJ, van der Ham M, Prinsen BH, Visser G, Verhoeven-Duif NM. Differences between acylcarnitine profiles in plasma and bloodspots. Mol Genet Metab. 2013, 110:116-21. 10.1016\/j.ymgme.2013.04.008","journal-title":"Mol Genet Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s1570-0232(03)00310-6","article-title":"Effect of supplementation with L-carnitine at a small dose on acylcarnitine profiles in serum and urine and the renal handling of acylcarnitines in a patient with multiple acyl-coenzyme A dehydrogenation defect","volume":"792","author":"Yoshino M","year":"2003","unstructured":"Yoshino M, Tokunaga Y, Watanabe Y, et al.. Effect of supplementation with L-carnitine at a small dose on acylcarnitine profiles in serum and urine and the renal handling of acylcarnitines in a patient with multiple acyl-coenzyme A dehydrogenation defect. J Chromatogr B Analyt Technol Biomed Life Sci. 2003, 792:73-82. 10.1016\/s1570-0232(03)00310-6","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1751143719889766","article-title":"Rhabdomyolysis caused by carnitine palmitoyltransferase 2 deficiency: a case report and systematic review of the literature","volume":"21","author":"Ivin N","year":"2020","unstructured":"Ivin N, Della Torre V, Sanders F, Youngman M. Rhabdomyolysis caused by carnitine palmitoyltransferase 2 deficiency: a case report and systematic review of the literature. J Intensive Care Soc. 2020, 21:165-73. 10.1177\/1751143719889766","journal-title":"J Intensive Care Soc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/tsaco-2021-000836","article-title":"Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee clinical consensus document","volume":"7","author":"Kodadek L","year":"2022","unstructured":"Kodadek L, Carmichael Ii SP, Seshadri A, et al.. Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee clinical consensus document. Trauma Surg Acute Care Open. 2022, 7:e000836. 10.1136\/tsaco-2021-000836","journal-title":"Trauma Surg Acute Care Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/189479-myopathic-carnitine-palmitoyltransferase-ii-cpt-ii-deficiency-a-rare-cause-of-acute-kidney-injury-and-cardiomyopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:43Z","timestamp":1707509263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/189479-myopathic-carnitine-palmitoyltransferase-ii-cpt-ii-deficiency-a-rare-cause-of-acute-kidney-injury-and-cardiomyopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.46595","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,6]]}}}